Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;35(12):e13343.
doi: 10.1111/jne.13343. Epub 2023 Oct 25.

European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours

Beata Kos-Kudła  1 , Justo P Castaño  2 , Timm Denecke  3 , Enrique Grande  4 , Andreas Kjaer  5 , Anna Koumarianou  6 , Louis de Mestier  7 , Stefano Partelli  8 , Aurel Perren  9 , Stefan Stättner  10 , Juan W Valle  11   12 , Nicola Fazio  13
Affiliations
Free article

European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours

Beata Kos-Kudła et al. J Neuroendocrinol. 2023 Dec.
Free article

Abstract

This ENETS guidance paper for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET) has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF-Pan-NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday clinical practice. Our many years of experience in this field are still being verified in the light of the results of new clinical, which set new ways of proceeding in NEN. The treatment of NF-Pan-NEN still requires a decision of a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.

Keywords: diagnostics; guideline; neuroendocrine tumour; pancreatic nonfunctioning neuroendocrine tumour; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
    1. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335-1342.
    1. Kasumova GG, Tabatabaie O, Eskander MF, Tadikonda A, Ng SC, Tseng JF. National rise of primary pancreatic carcinoid tumors: comparison to functional and nonfunctional pancreatic neuroendocrine tumors. J Am Coll Surg. 2017;224(6):1057-1064.
    1. Yang Z, Shi G. Comparative outcomes of pancreatic neuroendocrine neoplasms: a population-based analysis of the SEER database. Eur J Surg Oncol. 2022;48:2181-2187.
    1. Aysal A, Agalar C, Egeli T, et al. Reconsideration of clinicopathologic prognostic factors in pancreatic neuroendocrine tumors for better determination of adverse prognosis. Endocr Pathol. 2021;32(4):461-472.

MeSH terms

Supplementary concepts